Announcements Trials
Browse Landscape

Phase

Phase 3 23Phase 2 13Phase 4 3Phase 1 3Phase 1/2 2

Status

Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 45NETWORK 7NIH 5INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 2Plasma cell 1Other hematologic neoplasm 1

Conditions

Psoriasis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Multiple Myeloma 1Lymphoma, Follicular 1

Interventions

pembrolizumab 301Paclitaxel 206Carboplatin 199Gemcitabine 173Cisplatin 138Docetaxel 137Cyclophosphamide 135Nivolumab 129Bevacizumab 118Injections 111fludarabine 95atezolizumab 91Pemetrexed 90Dexamethasone 90Cetuximab 90Fluorouracil 84Irinotecan 77Rituximab 72Capecitabine 72venetoclax 70Azacitidine 70130-nm albumin-bound paclitaxel 67Leucovorin 65Fulvestrant 58Oxaliplatin 57durvalumab 56Trastuzumab 56Lenalidomide 55Ipilimumab 55Midazolam 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × Methotrexate × Clear all
NCT04960579 2026-04-24

MM

Poseida Therapeutics, Inc.

Phase 1 Active not recruiting
275 enrolled
Plasma cell

Multiple Myeloma

NCT02303821 2025-06-04

Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia

Amgen

Phase 1 Completed
141 enrolled 37 charts
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03424629 2018-04-20

Safety and Efficacy of UC-MSCs in Patients With Plaque Psoriasis

Tianjin Ever Union Biotechnology Co., Ltd.

Phase 1 Unknown
57 enrolled
Lymphoid

Lymphoma, Follicular, Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡